ABL vs ABUS

Comparison between Abacus Global Management Inc. (ABL, Company) and Arbutus Biopharma Corp (ABUS, Company).

ABL is from the Financial Services sector, while ABUS is from the Healthcare sector.

ABL vs ABUS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ABL(COMPANY)	ABUS(COMPANY)
Market Cap	$813M	$811M
Max Drawdown	N/A	92.96%
Sharpe Ratio	0.00	0.56
5Y Beta	N/A	0.90
Industry	Insurance - Life	Biotechnology
P/E Ratio	20.47	5.06
Forward P/E	10.57	10.25
PEG Ratio	N/A	0.00
Debt to Equity	79.02%	0.00%
Free Cash Flow Yield	15.59%	-4.23%
P/S Ratio	N/A	4.34
P/B Ratio	N/A	3.23

Market Cap

Winner

ABL

$813M

ABUS

$811M

Max Drawdown

ABL

N/A

ABUS

92.96%

Sharpe Ratio

ABL

0.00

Winner

ABUS

0.56

5Y Beta

ABL

N/A

ABUS

0.90

Industry

ABL

Insurance - Life

ABUS

Biotechnology

P/E Ratio

ABL

20.47

Winner

ABUS

5.06

Forward P/E

ABL

10.57

Winner

ABUS

10.25

PEG Ratio

ABL

N/A

ABUS

0.00

Debt to Equity

ABL

79.02%

Winner

ABUS

0.00%

Free Cash Flow Yield

Winner

ABL

15.59%

ABUS

-4.23%

P/S Ratio

ABL

N/A

ABUS

4.34

P/B Ratio

ABL

N/A

ABUS

3.23

ABL vs ABUS - Historical Returns

Returns include dividend reinvestment.

Period	ABL	ABUS
1 month	N/A	-1.16%
3 months	N/A	-1.39%
6 months	N/A	-9.55%
1 year	N/A	+18.99%
5 years(CAGR)	N/A	+5.37%
10 years(CAGR)	N/A	+2.40%
Max(CAGR)	+0.00%	-7.97%

ABL

N/A

ABUS

-1.16%

ABL

N/A

ABUS

-1.39%

ABL

N/A

ABUS

-9.55%

ABL

N/A

ABUS

+18.99%

5Y(CAGR)

ABL

N/A

ABUS

+5.37%

10Y(CAGR)

ABL

N/A

ABUS

+2.40%

Max(CAGR)

Winner

ABL

+0.00%

ABUS

-7.97%

ABL vs ABUS - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	ABL	ABUS
2026	+0.00%	-10.69%
2025	N/A	+46.20%
2024	N/A	+26.25%
2023	N/A	+12.11%
2022	N/A	-41.46%
2021	N/A	+6.87%
2020	N/A	+20.75%
2019	N/A	-30.50%
2018	N/A	-29.72%
2017	N/A	+102.00%
2016	N/A	-45.80%
2015	N/A	-57.62%